State of Wisconsin Investment Board
RPRX icon

State of Wisconsin Investment Board’s Royalty Pharma RPRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
213,373
+1,745
+0.8% +$90.8K 0.02% 596
2026
Q1 		$10.2M Buy
211,628
+4,677
+2% +$205K 0.02% 655
2025
Q4 		$8M Sell
206,951
-2,541
-1% -$96.9K 0.02% 790
2025
Q3 		$7.39M Buy
209,492
+9,746
+5% +$353K 0.02% 792
2025
Q2 		$7.2M Sell
199,746
-39,803
-17% -$1.32M 0.02% 788
2025
Q1 		$7.46M Buy
239,549
+29,550
+14% +$937K 0.02% 759
2024
Q4 		$5.36M Sell
209,999
-6,966
-3% -$185K 0.01% 920
2024
Q3 		$6.14M Buy
216,965
+15,738
+8% +$436K 0.02% 871
2024
Q2 		$5.31M Sell
201,227
-1,149
-0.6% -$31.9K 0.01% 890
2024
Q1 		$6.15M Buy
202,376
+5,438
+3% +$160K 0.02% 877
2023
Q4 		$5.53M Sell
196,938
-5,769
-3% -$159K 0.02% 936
2023
Q3 		$5.5M Buy
202,707
+6,544
+3% +$194K 0.02% 886
2023
Q2 		$6.03M Buy
196,163
+9,100
+5% +$308K 0.02% 866
2023
Q1 		$6.74M Sell
187,063
-24,633
-12% -$913K 0.02% 797
2022
Q4 		$8.37M Sell
211,696
-21,289
-9% -$889K 0.03% 659
2022
Q3 		$9.36M Sell
232,985
-44,823
-16% -$1.91M 0.03% 598
2022
Q2 		$11.7M Buy
277,808
+28,475
+11% +$1.17M 0.03% 569
2022
Q1 		$9.71M Buy
249,333
+75,146
+43% +$2.95M 0.02% 796
2021
Q4 		$6.94M Buy
174,187
+62,222
+56% +$2.42M 0.01% 916
2021
Q3 		$4.05M Buy
111,965
+7,341
+7% +$285K 0.01% 1097
2021
Q2 		$4.29M Sell
104,624
-3,418
-3% -$145K 0.01% 1093
2021
Q1 		$4.71M Buy
108,042
+54,172
+101% +$2.57M 0.01% 1039
2020
Q4 		$2.7M Buy
53,870
+42,450
+372% +$1.8M 0.01% 1142
2020
Q3 		$480K Buy
+11,420
New +$490K ﹤0.01% 1488

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wisconsin Investment Board's RPRX Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Royalty Pharma (RPRX) stake by 0.82% in Q2 2026, buying an estimated $90.8K and bringing the position to 213,373 shares worth $12M. The position accounts for 0.02% of the portfolio, ranked #596.

State of Wisconsin Investment Board first reported a position in RPRX in Q3 2020 and has held it in 24 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • State of Wisconsin Investment Board held 213,373 shares of Royalty Pharma worth $12M as of Q2 2026.
  • State of Wisconsin Investment Board bought 1,745 Royalty Pharma shares in Q2 2026, an estimated $90.8K.
  • Royalty Pharma made up 0.02% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #596 holding.
  • State of Wisconsin Investment Board first reported a position in Royalty Pharma in Q3 2020 and has held it in 24 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.